Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromelalgia.

Mark D. P. Davis1, Thom Rooke

  • 1Department of Dermatology and the Gonda Vascular Center, Mayo Clinic and Mayo Foundation, 200 First Street, SW, Rochester, MN 55905, USA. davis.mark2@mayo.edu

Current Treatment Options in Cardiovascular Medicine
|May 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plethysmography compared to ultrasound for the evaluation of chronic venous insufficiency.

Vascular medicine (London, England)·2026
Same author

Rapid post exercise venous refilling time is an independent contributor to chronic venous insufficiency.

Journal of vascular surgery. Venous and lymphatic disorders·2025
Same author

Machine Learning Analysis of Facial Photographs for Predicting Bicuspid Aortic Valve.

Mayo Clinic proceedings. Digital health·2025
Same author

Relationship between calf muscle pump function and severity of chronic venous disease.

Vascular medicine (London, England)·2025
Same author

Reduced calf muscle pump function is not explained by handgrip strength measurements.

Journal of vascular surgery. Venous and lymphatic disorders·2024
Same author

Reduced calf pump function and proximal deep vein incompetence are predictors for ipsilateral deep vein thrombosis.

Vascular medicine (London, England)·2022
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Effective erythromelalgia treatment remains elusive due to limited research. Management requires a multidisciplinary approach, including patient education and targeted therapies for this challenging condition.

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Pain Management

Background:

  • Erythromelalgia presents significant management challenges with no consistently effective treatments.
  • Current therapeutic recommendations often lack robust evidence, relying on case reports and anecdotal data.
  • The condition necessitates a comprehensive, multidisciplinary approach for effective patient care.

Purpose of the Study:

  • To review the current state of erythromelalgia management.
  • To highlight the limitations in existing therapeutic research.
  • To outline a comprehensive approach to managing erythromelalgia patients.

Main Methods:

  • Literature review of studies on erythromelalgia treatment.
  • Analysis of case reports and small case series.

Related Experiment Videos

  • Synthesis of recommendations for a multidisciplinary management strategy.

    • Main Results:

    • A significant lack of high-quality studies evaluating erythromelalgia therapies.
    • Current management strategies are largely based on limited evidence.
    • Effective treatment often requires addressing underlying factors and utilizing a combination of therapies.

    Conclusions:

    • Consistent and effective treatments for erythromelalgia are lacking.
    • Further rigorous research is crucial to establish evidence-based therapeutic guidelines.
    • A holistic management plan incorporating patient education, trigger avoidance, and pharmacological interventions is essential.